Keywords: amylin, shares, plunge, possible, byetta, lar, approval

Amylin shares plunge 26% on possible Byetta LAR US approval delay

Article | 10 November 2008

Print This

Shares in Amylin Pharmaceuticals plunged 25.8%, to close at $7.94 on November 4, after the US drugmaker announced that the approval of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in